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The rare incidence of pulmonary alveolar micro-
lithiasis has not allowed us to describe in detail
main characteristics of the disease. However, an
overview of the world literature may provide some
guidelines relative to the epidemiology, familiarity,
clinical and pathological features together with
possible therapies.
Epidemiology
Although the first few pulmonary alveolar micro-
lithiasis cases have been reported by Malpighi,1 the
term was first coined by Phur2 in the 1930s in order
to indicate the main feature of the disease. Indeed,
the essence of this disorder is the presence in
pulmonary alveolus of round shaped little bodies
containing concentric calcareous lamellas.
The disease is present in all the continents and
does not have any preference for specific races or
countries. The incidence is similar in both sexes and
it is higher in age brackets between 20 to 50 years.
However, Mariani e Lopez3 reported two cases of
microlithiasis at the age of 2 years whereas a case
of neonatal microlithiasis occurring in premature
twins was reported by Caffrey et al.4 Finally, a case
of this disease occurring at the age of 72 years was
described by Barnard and it is the oldest case which
has been reported up till now.5 According to recent
data6 about 300 cases have been published so far.
Most of them were reported in Europe then in Asia,
North America, Africa and Oceania (Table 1). The
country with the highest number of cases is Turkey
(56 cases) then Italy (36 cases). In reference to
Italian record of cases, 64% of them were found in
Southern Italy (Puglia, Campania, Basilicata) as
opposed to the remaining 36% which were found
in Nothern and Central Italy (Lazio, Abruzzo,
Romagna, Piemonte).
Familiarity and possible pathogenetic
hypotheses
The analysis of reported cases reveals that the
disease is prevalent amongst family units. Famil-
iarity exhibiting horizontal relationship was found
amongst 5 sisters by Perosa and Ramunni (family
L.A.),7 amongst 4 sisters by Gomez-Esquerra,
amongst 2 brothers by Martinez, 8 amongst 4 sisters
by Sosman9 and amongst 3 sisters by Mariani.10 One
case of familiarity exhibiting vertical relationship
with parent-child ratio of 1:1 was described by
Mikhailov11 and another one was reported in
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Bulgaria. Familiarity exhibiting both horizontal and
vertical relationship was reported by Perosa and
Ramunni7 in a family unit of 5 people (family Mu): 2
sisters and 3 children of one of the sisters.
Therefore, this represents the largest family group
as well as the family with the highest parent–child
ratio of pulmonary alveolar microlithiasis reported
to date in the literature. Also, it provides support
for the hypothesis that the disease may be
hereditary and related to an underlying autosomal
recessive gene disorder. Furthermore more recent
reports may support this hypothesis. Indeed,
Castellana and coll12 described a case of micro-
lithiasis in a patient who was related to a family in
whom Perosa and Ramunni found the 5 cases of this
same rare condition. The case described by
Castellana was a cousin of one of the two sisters
indicated by Perosa and Ramunni suggesting the
hypothesis of a possible hereditary transmission.
Although clinical features of this disease have
been well described, the mechanism which may
induce microliths to form is unknown. Inhalation of
specific powders was thought to be involved in the
origin of microliths as some patients lived in the
same rural district and worked on the same farm-
lands.7 Nevertheless, the analysis of chemical
composition of the land (characteristic ‘‘red land’’
containing silica, iron, aluminium, titanium)
together with the absence of microlithiasis in other
areas provided with land exhibiting the same
chemical composition had not confirmed this
hypothesis. Furthermore, structural affinities which
have been found in microliths and in ‘‘corpora
amilacea’’ hypothesized that the origin of both
compounds could be similar. Therefore, a possible
condensation of alveolar mucus was thought to be
involved in the formation of microliths as the origin
of ‘‘corpora amilacea’’ had been hypothesized to
be connected to this mechanism. On the other
hand, the condensation of alveolar mucus could
require the presence of an excess of this substance
in pulmonary alveolus. This excess might be related
to a reflux of mucus in alveolus connected to
reduced activity of bronchial ciliated epithelium. In
accordance to this hypothesis, some studies were
performed in order to evaluate the lung mucocili-
ary function in patients with microlithiasis. D’Ad-
dabbo et al.13 reported that in patients with
microlithiasis the clearance of inhaled radiogold
particles was shown to be significantly slower as
compared with controls. In addition, the pattern of
serial scans clearly indicated that the lung muco-
ciliary function was impaired in patients with
microlithiasis. This may suggest that slowing of
the clearance may represent a pathogenetic factor
capable of favouring the formation of alveolar
microliths. Results obtained by Chinacoti et al.14 in
patients who were accustomed to smoke ‘‘snuff’’ (a
particular mixture of tobacco and oriental gum)
seems to be in favour of this hypothesis. Indeed, 9
cases of pulmonary alveolar microlithiasis were
described among these smokers and experimental
results demonstrated the ability of the above-
mentioned mixture to inhibit the activity exerted
by bronchial ciliated epithelium. Furthermore,
results coming from other experimental studies
suggested the possibility either of an alveolar
thesaurotic process15 or an alveolar congenital
enzymatic defect. This last abnormality could
induce the development of a far too alkaline
alveolar microenvironment which may lead to
precipitation of calcium salts with following for-
mation of microliths.
Finally, cases of pulmonary alveolar microlithiasis
secondary to lung cancer, tubercular remains and
pleural mesothelioma have been reported too.16
Pathological features
Pulmonary alveolar microlithiasis-related patholo-
gical features may appear either confined to
particular areas of the lung or widespread. In the
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Table 1 World distribution of pulmonary alveolar
microlithiasis.
Europe: 123 cases
Italy 36, France 18, Great Britain
16, Germany 14, Spain 12,
Yugoslavia 7 Russia 6, Bulgaria 4,
Austria 3, Switzerland 3,
Czechoslovakia 2, Hungary 2
Asia: 115 cases
Turkey 56, Japan 20, Thailand 14,
India 13, Saudi Arabia 6, China 2,








Colombia 6, Brazil 2, Argentina 1
Africa: 7 cases
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widespread form, lungs exhibit increased weight
(about 5 kg) and consistency as well. External
surface of lungs may appear granular because of
protrusion of microliths under visceral pleura.
Furthermore, areas of bullous emphysema may be
found both on the anterior margin and at the apex
of lungs. In the confined form, microliths are
present in restricted areas of lungs only exhibiting
the same pathological features as those of the
widespread form. The diameter of microliths is
about of 0.2 m and, in this case, microliths may fill
the pulmonary alveolus whose wall and septums
may appear to be pressed. In the case of smaller
sizes a space between alveolus wall and microliths
may occur; it may be filled by macrophages.
Microliths are not uniformly distributed in lungs as
there are very few at the upper regions as opposed
to the lower ones where they are more numerous.
In reference to histology, microliths consist of
calcareous concentric lamellas which are placed
around a central nucleus exhibiting an amorphous
or granular aspect. Chemically, microliths consist of
large amounts of calcium and phosphorus which are
mixed to small amounts of magnesium and alumi-
nium. Tinctorial properties indicate that microliths
are Pas-positive.
Clinical features
The dissociation between definite X-ray pattern of
lungs and relative poor clinical symptoms is one of
the most common characteristics of the disease.
The family anamnesis does not report significant
elements. Patients may report previous recurrent
bronchopneumonias which are not known to have
been favourite in their onset from the preexisting
pneumopathy or to assume the role of predisposing
factor in the appearance of alveolar microlithiasis.
Clinical symptoms are often absent and, in this
case, diagnosis of the disease may be sustained by a
specific X-ray pattern of lungs only. In other cases,
patients may report a certain degree of dyspnea
with a productive cough, sporadic hemoptysis with
thoracic pains; rales may be found at lung bases by
physical examination of the chest. X-ray pattern of
lungs consists of dissemination of nodules of almost
equal sizes among them. They are as radioopaque
as tissues containing calcium as well as they are
widespread in all the pulmonary regions so much
that lungs appear to be sprinkled with sand (Figs. 1
and 2).17,18 However, the distribution of nodules
may be irregular; at times, they are mainly
distributed at lung bases and disappear into the
apexes; at times, they may be more evident at
hilum and disappear into the peripheral areas of
lungs; at times, they are mainly distributed along
bronchuses and vases. The computerized axial
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Figure 1 Pulmonary alveolar microlithiasis: X-ray
pattern of lungs. By Lauta V.M.: ‘‘La funzione undulopo-
dica dell’epitelio bronchiale nella microlitiasi endoalveo-
lare del polmone studiata con curve di eliminazione di
particelle di Au198 e con scintigrafie polmonari’’. Atti Ac
Pugl Sci 1980; 18: 13–44.
Figure 2 Pulmonary alveolar microlithiasis: X-ray
pattern of lungs. By Lauta V.M.: ‘‘La funzione undulopo-
dica dell’epitelio bronchiale nella microlitiasi endoalveo-
lare del polmone studiata con curve di eliminazione di
particelle di Au198 e con scintigrafie polmonari’’. Atti Ac
Pugl Sci 1980; 18: 13–44.
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tomography of the chest performed with high
resolution technique provides evidence of numer-
ous and tiny alveolar calcareous microcorpuscles
with areas of bullous emphysema at the upper lobes
of lungs.19
Laboratory data
Routine tests (ESR, blood nitrogen, glycemia,
urinalysis) exhibit normal values except for a
certain tendency to polycythemia at the hemo-
gram. Usually, no microliths is possible to be
detected in the sputum whereas they may be found
in the broncho-alveolar lavage fluid by chemical
examination.20,21 Pulmonary function tests exhibit
a proportional reduction of FEV1 (forced expiratory
volume in 1 s) and VC (vital capacity) values
together with a decrease of FRC (functional
residual capacity), RV (residual volume) and TLC
(total lung capacity) values. The alveolocapillary
diffusion is normal as opposed to a mild increase
of plethysmography resistance values. The evolu-
tive course of the disease leads to pulmonary
insufficiency which is related to the increase of
microliths number in several areas of the lungs.
Usually, the exitus occurs by 10–15 years from the
diagnosis, even if Castellana and coll6 point out a
pulmonary alveolar microlithiasis case revisited
after 44 years from the diagnosis. Authors report
that this is the longest living case in world
literature, attesting this disease is not very
evolutive in any cases.
Diagnosis
The diagnosis of pulmonary alveolar microlithiasis
is based mainly on the already mentioned dissocia-
tion between definite X-ray pattern of lungs and
relative poor clinical symptoms.
However, a differential diagnosis must be per-
formed in reference to similar X-ray patterns
occurring in other pneumopathies. Indeed, the
sarcoidosis is characterized by a similar dissociation
between clinical and radiological elements. Never-
theless, lung nodules exhibit more stable sizes
together with a higher radiopacity in patient with
microlithiasis than in those with sarcoidosis. In
addition, epithelioid cells as well as Langhan’s giant
cells are possible to be detected in the broncho-
alveolar lavage fluid by cytologic examination in
patients with sarcoidosis who may also exhibit
positivity for the Kweim test. Furthermore, the
stable sizes and the higher radiopacity expressed by
lung nodules in microlithiasis may also allow the
differential diagnosis between this pneumopathy
and miliary tuberculosis. Common involvement of
hilar lymph nodes during the development of lung
tuberculosis may be an additional element in this
differential diagnosis. Idiopathic and secondary
pulmonary emosiderosis may be taken into con-
sideration for a possible differential diagnosis with
microlithiasis. The coexistence of some clinical
symptoms such as hemoptysis, anemia, latent
jaundice are in favour of idiopathic pulmonary
emosiderosis whereas heart trouble inducing hy-
pertension of pulmonary circulation sustain the
diagnosis of secondary pulmonary emosiderosis.
Finally, the dissociation between radiological and
clinical factors may also be found in some pneu-
moconiosis such as the anthracosis and silicosis. In
this case, previous inhalation of relative mineral
particles related to a specific working activity may
make differential diagnosis with microlithiasis
easier.
Therapy
The inability to identify clear etiological and
pathogenetic elements makes the therapeutic
approach difficult. In any rate, it is palliative and
unrealistc as well. Gocmen and coll22 proposed the
use of diphosphonate in order to reduce calcium
phosphate precipitation in pulmonary alveolus. This
treatment would have induced a little improve-
ment of lungs’ X-ray pattern only without any
involvement of evolutive course of the disease. The
use of steroids proved to be ineffective whereas
therapeutic broncho-alveolar lavage fluid (BAL)
gave rise to controversial opinions. The use of BAL
for a therapeutic aim is based on the intake of
physiological salt solution in pulmonary airways
with the following drainage of an identical amount
of liquid in order to remove the majority of
microliths from alveolus. Although the theoretical
principle seems to be sound as well as results
coming from some clinical studies report valid
collections of microliths, according to some Authors
the evolutive course of the disease does not seem
to be involved.19,20,23 However, other results which
indicate the possibility of a control of the course of
the disease by this therapeutic method have been
reported.21
In conclusion, these elements indicate more and
more the requirement that new fields of research





Pulmonary alveolar microlithiasis is characterized
by the presence in pulmonary alveolus of round
shaped little bodies containing concentric calcar-
eous lamellas. The incidence is similar in all
continents, in both sexes and it is higher in age
brackets between 20 and 50 years. The disease is
prevalent among family units. Clinical reports may
suggest the hypothesis that the disease may be
hereditary. Pathogenetic hypotheses may indicate
that a reduced lung mucociliary function leading to
an excess of alveolar mucus may induce the
formation of alveolar microliths by mucus conden-
sation.
Microliths may appear either confined in particu-
lar areas of the lung or widespread. Chemically,
microliths consist of large amounts of calcium and
phosphorus and, in reference to histology, they
consist of calcareous concentric lamellas which are
placed around an amorphous or granular central
nucleus. The dissociation between definite X-ray
pattern of lungs and relative poor clinical symptoms
is the most common characteristics of the disease.
However, a certain degree of dyspnea with a
productive cough may occur together with a
sporadic hemoptysis and thoracic pains. X-ray
pattern of the lung reveals dissemination of radio-
opaque nodules which may make lungs appear to be
sprinkled with sand.
The evolutive course of the disease leads to
pulmonary insufficiency which is related to the
increase of number of microliths in several areas of
lungs.
The inability to identify clear etiological and
pathogenetic elements makes difficult therapeutic
approach which is palliative such as the use of
diphosphonate, steroids and therapeutic BAL.
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